Abbott India Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 5/6
Abbott India verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 17.2%, während die Gewinne der Branche Pharmaceuticals jährlich um gewachsen und zwar um 13.4%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 9.2%. Die Eigenkapitalrendite von Abbott India beträgt 36.5% und die Nettomargen betragen 21.2%.
Wichtige Informationen
17.2%
Wachstumsrate der Gewinne
17.2%
EPS-Wachstumsrate
| Pharmaceuticals Wachstum der Industrie | 17.5% |
| Wachstumsrate der Einnahmen | 9.2% |
| Eigenkapitalrendite | 36.5% |
| Netto-Marge | 21.2% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Aufschlüsselung der Einnahmen und Ausgaben
Wie Abbott India Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 60,661 | 12,847 | 7,073 | 0 |
| 30 Jun 24 | 59,275 | 12,390 | 7,026 | 0 |
| 31 Mar 24 | 58,489 | 12,012 | 6,910 | 0 |
| 31 Dec 23 | 57,534 | 11,456 | 6,799 | 0 |
| 30 Sep 23 | 56,384 | 10,814 | 6,760 | 0 |
| 30 Jun 23 | 55,236 | 10,340 | 6,828 | 0 |
| 31 Mar 23 | 53,487 | 9,494 | 6,855 | 0 |
| 31 Dec 22 | 52,654 | 9,294 | 7,285 | 0 |
| 30 Sep 22 | 51,632 | 8,818 | 7,348 | 0 |
| 30 Jun 22 | 50,058 | 8,086 | 7,422 | 0 |
| 31 Mar 22 | 49,133 | 7,987 | 7,356 | 0 |
| 31 Dec 21 | 47,598 | 7,398 | 6,852 | 0 |
| 30 Sep 21 | 46,308 | 7,177 | 6,632 | 0 |
| 30 Jun 21 | 44,636 | 7,061 | 6,296 | 0 |
| 31 Mar 21 | 43,100 | 6,907 | 6,126 | 0 |
| 31 Dec 20 | 41,757 | 6,492 | 6,345 | 0 |
| 30 Sep 20 | 41,586 | 6,587 | 6,339 | 0 |
| 30 Jun 20 | 41,585 | 6,563 | 4,844 | 0 |
| 31 Mar 20 | 40,931 | 5,929 | 6,227 | 0 |
| 31 Dec 19 | 40,383 | 5,952 | 6,357 | 0 |
| 30 Sep 19 | 39,077 | 5,255 | 6,231 | 0 |
| 30 Jun 19 | 38,326 | 4,849 | 6,076 | 0 |
| 31 Mar 19 | 36,786 | 4,503 | 6,022 | 0 |
| 31 Dec 18 | 35,606 | 4,372 | 5,727 | 0 |
| 30 Sep 18 | 34,941 | 4,355 | 5,575 | 0 |
| 30 Jun 18 | 34,460 | 4,354 | 5,506 | 0 |
| 31 Mar 18 | 32,985 | 4,012 | 5,325 | 0 |
| 31 Dec 17 | 32,242 | 3,432 | 4,760 | 0 |
| 30 Sep 17 | 30,893 | 3,134 | 4,727 | 0 |
| 30 Jun 17 | 28,794 | 2,509 | 4,613 | 0 |
| 31 Mar 17 | 29,026 | 2,766 | 4,517 | 0 |
| 31 Dec 16 | 28,959 | 2,980 | 4,402 | 0 |
| 30 Sep 16 | 28,097 | 2,802 | 4,403 | 0 |
| 30 Jun 16 | 27,293 | 2,663 | 4,403 | 0 |
| 31 Mar 16 | 26,145 | 2,553 | 4,444 | 0 |
| 31 Dec 15 | 25,380 | 2,504 | 6,194 | 0 |
| 30 Sep 15 | 24,504 | 2,445 | 6,109 | 0 |
| 30 Jun 15 | 23,950 | 2,466 | 6,016 | 0 |
| 31 Mar 15 | 22,893 | 2,290 | 4,002 | 0 |
| 31 Dec 14 | 22,008 | 2,176 | 5,943 | 0 |
| 30 Sep 14 | 21,103 | 2,065 | 5,706 | 0 |
| 30 Jun 14 | 19,776 | 1,880 | 5,558 | 0 |
| 31 Mar 14 | 18,694 | 1,668 | 5,541 | 0 |
| 31 Dec 13 | 17,527 | 1,601 | 2,313 | 0 |
Qualität der Erträge: ABBOTINDIA hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: ABBOTINDIADie aktuellen Gewinnspannen (21.2%) sind höher als im letzten Jahr (19.2%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: ABBOTINDIAIn den letzten 5 Jahren sind die Gewinne von 17.2% jährlich gestiegen.
Beschleunigtes Wachstum: ABBOTINDIADas Gewinnwachstum des Unternehmens im letzten Jahr (18.8%) übertrifft seinen 5-Jahres-Durchschnitt (17.2% pro Jahr).
Erträge im Vergleich zur Industrie: ABBOTINDIA Das Gewinnwachstum im vergangenen Jahr (18.8%) übertraf nicht die Entwicklung der Branche Pharmaceuticals 20% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: ABBOTINDIADie Eigenkapitalrendite des Unternehmens (36.5%) wird als hoch angesehen.